Archiv für die gesamte Virusforschung

, Volume 27, Issue 2–4, pp 255–267 | Cite as

Antiviral action of gliotoxin

  • J. K. McDougall


Antiviral activity of gliotoxin can be demonstrated at approximately one-tenth of the concentration which produces toxic effects in tissue culture cells and embryonated eggs.

The inhibition of picornaviruses in tissue culture varies quantitatively according to the strain of virus. Inhibition of influenza and parainfluenza viruses is found in embryonated eggs and chorioallantoic membrane pieces. No activity was found against any of the myxoviruses tested in tissue culture or against viruses containing deoxyribonucleic acid.

Gliotoxin acts on a stage in the intracellular synthesis of susceptible picornaviruses and results in inhibition of the production of virus specific proteins.

The adsorption of gliotoxin by cellsin vitro is rapid. Subsequent washing of the cells with gliotoxin-free medium does not result in a reversal of inhibition of virus synthesis.

A related compound, dethiogliotoxin, which does not contain the disulphide bridge present in gliotoxin appears to have no specific antiviral or antibiotic activity. It is suggested that the antiviral activity of gliotoxin is associated with the presence of the linked sulphur atoms in the molecule.


Influenza Tissue Culture Toxic Effect Specific Protein Antiviral Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bell, M. R., J. E. Johnson, B. S. Wildi, andR. B. Woodward: J. Amer. chem. Soc.80, 1001 (1958).Google Scholar
  2. Brammer, K. W., and M.Page: Personal communication (1966).Google Scholar
  3. Coons, A. H., andM. H. Kaplan: J. exp. Med.91, 1 (1950).Google Scholar
  4. Crowther, D., andJ. L. Melnick: Virology15, 65 (1961).Google Scholar
  5. Eason, R., M. J. Cline, andR. M. S. Smellie: J. biol. Chem.238, 3978 (1963).Google Scholar
  6. Eggers, H. J., andI. Tamm: J. exp. Med.113, 657 (1961).Google Scholar
  7. Eggers, H. J., andI. Tamm: Virology18, 426 (1962).Google Scholar
  8. Eggers, H. J., andI. Tamm: Nature (Lond.)197, 1327 (1963).Google Scholar
  9. Eggers, H. J., N. Ikegami, andI. Tamm: Ann. N.Y. Acad. Sci.130, 167 (1965).Google Scholar
  10. Fazekas de St Groth, S., andD. O. White: J. Hyg. (Lond.)56, 151 (1958).Google Scholar
  11. Larin, N. M., M. P. Copping.R. Herbst-Laier, B. Roberts, andR. B. M. Wenham: Chemotherapia (Basel)10, 12 (1965).Google Scholar
  12. Loddo, B., S. Muntoni, A. Spanedda, G. Brotzu, andW. Ferrari: Nature (Lond.)197, 315 (1963).Google Scholar
  13. Mayor, H. D.: Tex. Rep. Biol. Med.19, 106 (1961).Google Scholar
  14. Melnick, J. L., D. Crowther, andJ. Barrera-Oro: Science, N.Y.134, 557 (1961).Google Scholar
  15. Morgan, J. F., H. J. Morton, andR. C. Parker: Proc. Soc. exp. Biol. (N.Y.)73, 1 (1950).Google Scholar
  16. Renis, H. E., andD. A. Buthala: Ann. N.Y. Acad. Sci.130, 343 (1965).Google Scholar
  17. Rightsel, W. A., H. G. Schneider, B. J. Sloan, P. R. Graf, F. A. Millar, Q. R. Bartz, andJ. Ehrlich: Nature (Lond.)204, 1333 (1964).Google Scholar
  18. Sheffield, F. W.: Brit. J. exp. Path.42, 59 (1961).Google Scholar
  19. Stanley, N. F., andJ. A. Mills: Aust. J. exp. Biol. med. Sci.24, 133 (1946).Google Scholar
  20. Tamm, I., R. Bablanian, M. M. Nemes, C. H. Shunk, F. M. Robinson, andC. Folkers: J. exp. Med.113, 625 (1961).Google Scholar
  21. Tamm, I., andH. J. Eggers: Science (N.Y.)142, 24 (1963).Google Scholar
  22. Tamm, I., M. M. Nemes, andS. Osterhout: J. exp. Med.111, 339 (1960).Google Scholar
  23. Weindling, R.: Phytopathology22, 837 (1932).Google Scholar
  24. Weindling, R.: Phytopathology24, 1153 (1934).Google Scholar
  25. Weindling, R.: Phytopathology31, 11 (1941).Google Scholar
  26. Weindling, R., andO. H. Emerson: Phytopathology26, 1068 (1936).Google Scholar

Copyright information

© Springer-Verlag 1969

Authors and Affiliations

  • J. K. McDougall
    • 1
    • 2
  1. 1.Medical Research CouncilClinical and Population Cytogenetics Research Unit, Western General HospitalEdinburgh 4Scotland
  2. 2.Therapeutics Research DivisionPfizer Ltd.SandwichEngland

Personalised recommendations